Role of cytokines against invasive aspergillosis
- 1 April 2003
- journal article
- immunology
- Published by Wolters Kluwer Health in Reviews in Medical Microbiology
- Vol. 14 (2) , 63-72
- https://doi.org/10.1097/00013542-200304000-00003
Abstract
Aspergillus fumigatus is the most frequent causative agent of invasive aspergillosis, a predominant life-threatening opportunistic infection in immunocompromised individuals. A. fumigatus conidia reach the alveoli via inhalation, where the pulmonary alveolar macrophages (PAM) ingest and destroy them intracellularly by non-oxidative anti-fungal mechanisms. Circulating phagocytes (i.e., neutrophils and monocytes) can destroy hyphae that germinate from conidia, which escape phagocytosis by PAM, by both oxidative and non-oxidative mechanisms. In addition, other immune cells such as natural killer lymphocytes, tissue macrophages and platelets play an important role in host defence against A. fumigatus. Given that the vulnerability of immunocompromised patients is due mainly to qualitative and quantitative phagocytic deficiencies, the ability of cytokines to regulate the function of host defence cells is of great importance for the management of infections caused by A. fumigatus. Cytokines can augment or suppress the anti-fungal phagocyte function by altering oxidative burst, cell-mediated hyphal damage, phagocytosis, restoration of corticosteroid treatment effects, and secretion of other cytokines. The hemopoietic growth factors granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor as well as macrophage colony-stimulating factor, and the Th1 pattern cytokines interferon-γ, interleukin-12 and tumour necrosis factor-α augment phagocyte function against A. fumigatus, while interleukin-4, interleukin-10 and transforming growth factor-β suppress it. Furthermore, other cytokines such as interleukin-8, -13, -15, -18 and -25 may exhibit anti-Aspergillus effects. Finally, besides the direct immunomodulatory properties of cytokines, the latter may collaborate with anti-fungal drugs enhancing even more the inhibition of fungal growth by phagocytes. Therefore, combination of immunotherapy and anti-fungal chemotherapy might be an alternative therapeutic approach for controlling A. fumigatus infections successfully.Keywords
This publication has 51 references indexed in Scilit:
- RECOMBINANT HUMAN MACROPHAGE COLONY-STIMULATING FACTOR AUGMENTS PULMONARY HOST DEFENCES AGAINST ASPERGILLUS FUMIGATUSCytokine, 2001
- Invasive Pulmonary Aspergillosis Associated with Infliximab TherapyNew England Journal of Medicine, 2001
- Amphotericin B Activation of Human Genes Encoding for CytokinesThe Journal of Infectious Diseases, 1998
- Cationic peptides: a new source of antibioticsTrends in Biotechnology, 1998
- Interleukin-4 suppresses antifungal activity of human mononuclear phagocytes against Candida albicans in association with decreased uptake of blastoconidiaFEMS Immunology & Medical Microbiology, 1997
- Interleukin‐4 and interleukin‐10 inhibit nitric oxide‐dependent macrophage killing of Candida albicansEuropean Journal of Immunology, 1993
- Impairment of Neutrophil Antifungal Activity against Hyphae of Aspergillus fumigatus in Children Infected with Human Immunodeficiency VirusThe Journal of Infectious Diseases, 1993
- T Helper Cell Immune Dysfunction in Asymptomatic, HIV-1-Seropositive Individuals: The Role of TH1-TH2 Cross-RegulationPublished by S. Karger AG ,1992
- 1,4-Oligoglucosides Inhibit the Binding of Aspergillus fumigatus Conidia to Human MonocytesThe Journal of Infectious Diseases, 1991
- Partial Correction of the Phagocyte Defect in Patients with X-Linked Chronic Granulomatous Disease by Subcutaneous Interferon GammaNew England Journal of Medicine, 1988